114422.jpg
Explain the result with explanation and provide probable diagnosis
analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
"typhoid fever" AND "Widal test"
Lab Report Interpretation – Mrs. Sangeetha J., 48Y/F
Summary of abnormal findings
| Test | Result | Reference | Flag |
|---|---|---|---|
| Haemoglobin | 9.9 g/dl | 12.0–16.0 | ↓ Low (anemia) |
| WBC | 12,200 /cumm | 4,000–11,000 | ↑ High (leukocytosis) |
| Neutrophils | 80% | 40–70% | ↑ High (neutrophilia) |
| Lymphocytes | 15% | 20–40% | ↓ Low (relative lymphopenia) |
| PCV | 29.6% | 35.1–48.7% | ↓ Low |
| MCV | 74.9 fL | 83–101 | ↓ Low (microcytic) |
| MCH | 25.0 pg | 27–32 (typical) | ↓ Low (hypochromic) |
| Platelet count | 4.20 lakh/cumm | 1.5–4.0 lakh | ↑ Borderline high |
| ESR (1hr) | 68 mm | 0–20 (female) | ↑↑ Markedly high |
| CRP | 46.0 mg/L | < 6.0 | ↑↑ Markedly high |
| Widal – S. Typhi "O" | Positive 1:80 | - | Positive |
| Widal – S. Typhi "H" | Positive 1:40 | - | Positive |
| Widal – Para Typhi A(H)/B(H) | Negative | - | Negative |
What this pattern means
1. Acute inflammatory/infective response. The combination of raised WBC count with marked neutrophilia (80%) and relative lymphopenia, together with a strikingly elevated ESR (68 mm, more than 3x upper limit) and CRP (46 mg/L, nearly 8x upper limit), is a classic picture of an acute bacterial infection driving a systemic inflammatory response. CRP rises within hours of infection/tissue injury and correlates with severity; ESR rises more slowly and reflects ongoing inflammation - Tietz Textbook of Laboratory Medicine, and Campbell's Operative Orthopaedics note CRP and ESR are used together as standard "infection" markers.
2. Widal serology. Both S. Typhi "O" (1:80) and "H" (1:40) antibodies are positive, while Para Typhi A and B are negative. In an endemic area, a rising or significantly elevated O and H titer against S. Typhi (classically ≥1:160 in a single sample, or a 4-fold rise on paired samples) supports a diagnosis of typhoid (enteric) fever. However, textbooks (Jawetz Melnick & Adelberg's Microbiology; Sleisenger and Fordtran's) caution that the Widal test has significant limitations - cross-reaction with other Salmonella serotypes, false positives from past infection/vaccination in endemic populations, and false negatives especially early in illness. The CDC does not recommend Widal alone for confirming acute typhoid because baseline titers vary widely in endemic regions, and blood/bone marrow/stool culture remains the diagnostic gold standard (Park's Textbook of Preventive and Social Medicine; Sabiston Textbook of Surgery).
3. Anemia. Hb 9.9 g/dl with low MCV (74.9) and low MCH (25.0) but normal MCHC indicates a microcytic, mildly hypochromic anemia. In the context of an acute infective/inflammatory illness, this pattern is commonly seen with anemia of inflammation (anemia of chronic disease), which can present as normocytic or mildly microcytic (Harrison's Principles of Internal Medicine; Tietz Textbook of Laboratory Medicine). Given the patient's age and sex, coexisting iron deficiency (e.g., from menstrual blood loss or dietary causes) should also be considered as a contributing or independent cause and would need iron studies (serum iron, ferritin, TIBC) to differentiate.
4. Mildly elevated platelet count (4.20 lakh, upper-normal/borderline high) is consistent with a reactive response to infection/inflammation and is not concerning in isolation.
Probable diagnosis
Enteric (Typhoid) fever - supported by positive Widal reaction for S. Typhi O and H antigens, in a patient with an acute febrile/inflammatory picture (leukocytosis with neutrophilia, markedly raised CRP and ESR).
Note: leukocytosis with neutrophilia is a bit atypical for classic typhoid (which classically causes leukopenia), so this could represent early disease, a complication (e.g., intestinal perforation, secondary bacterial infection), or an alternate/co-existing bacterial infection. Blood culture (the gold standard) is strongly recommended to confirm S. Typhi bacteremia before starting or finalizing treatment, since Widal alone is not diagnostic.
Coexisting finding: Microcytic hypochromic anemia - most likely anemia of inflammation in the setting of acute infection, though iron deficiency anemia should be excluded with iron studies given the degree of microcytosis.
Recommendations for the clinician/patient
- Blood culture (ideally before/without prior antibiotics) to confirm S. Typhi.
- Clinical correlation: fever pattern, GI symptoms, abdominal exam, rose spots, hepatosplenomegaly.
- Iron studies (serum ferritin, iron, TIBC) and peripheral smear review to clarify the anemia.
- Repeat Widal titer in 7-10 days (paired sample) if diagnosis remains uncertain - a 4-fold rise strengthens the diagnosis.
- Treat as clinically indicated per local antibiotic sensitivity patterns for S. Typhi once confirmed.
A quick literature check found recent systematic reviews (2025) on typhoid fever epidemiology and risk factors (PMID: 40875987, 40753988, 40782891), but none specifically contradicts the well-established caveat that Widal serology alone is insufficient for definitive diagnosis - culture confirmation remains standard.
This interpretation is based on the report values alone; it does not replace an in-person clinical evaluation by the treating physician, who will correlate these results with symptoms, examination findings, and travel/exposure history.
Treatment
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
"typhoid fever" AND antibiotic treatment
Treatment Guidance – Based on Probable Diagnosis (Typhoid/Enteric Fever + Anemia of Inflammation)
Important caveat first: Widal positivity alone does not confirm typhoid fever, and antibiotic choice should ideally be guided by blood culture and local sensitivity patterns (multi-drug resistant and even XDR strains exist in some regions, e.g., Pakistan). The regimens below are standard textbook options - final drug and duration should be decided by the treating physician after clinical correlation and, if possible, culture results.
1. Antimicrobial therapy for typhoid (enteric) fever
Per Harrison's Principles of Internal Medicine, Goldman-Cecil Medicine, and Tintinalli's Emergency Medicine, first-line options for uncomplicated enteric fever include:
| Drug class | Example | Typical duration |
|---|---|---|
| Third-generation cephalosporin | Ceftriaxone (IV) | 10-14 days |
| Macrolide | Azithromycin (oral) | 7-10 days |
| Fluoroquinolone | Ciprofloxacin (oral) - only where fluoroquinolone resistance is not suspected | 7-10 days |
| Oral cephalosporin | Cefixime | 7-14 days |
A 2022 systematic review of 27 RCTs (cited in Harrison's) found no significant difference in treatment failure, relapse, or adverse events between ceftriaxone, fluoroquinolones, and azithromycin for enteric fever - so the choice often depends on local resistance patterns, severity, and whether oral or IV therapy is feasible. A more recent 2024 systematic review of RCTs (PMID: 39623850) similarly supports oral azithromycin as an effective, well-tolerated option comparable to other antimicrobials across age groups.
Because fluoroquinolone-resistant and even azithromycin-resistant S. Typhi strains have emerged in some endemic regions, empirical therapy with ceftriaxone or azithromycin is often preferred until sensitivity is known, switching to a narrower agent once culture/sensitivity results return.
Supportive care:
- Antipyretics (paracetamol) for fever
- Adequate oral/IV hydration
- Monitor for complications: intestinal perforation, GI bleeding, hepatitis, encephalopathy - especially if fever persists beyond 5-7 days of appropriate antibiotics or abdominal pain worsens (surgical review needed if perforation is suspected, per Bailey & Love's Short Practice of Surgery).
- Repeat CBC, CRP, and clinical review after 48-72 hours of antibiotics to confirm response (falling CRP/WBC, defervescence).
2. Management of the anemia (Hb 9.9, microcytic/hypochromic)
- The most effective treatment for anemia of chronic disease/inflammation is treating the underlying infection - Hb typically improves as the infective/inflammatory process resolves (Goldman-Cecil Medicine).
- Because the picture is also mildly microcytic, iron studies (serum ferritin, iron, TIBC/transferrin saturation) should be checked to rule out coexisting iron deficiency (common in women of this age, e.g., from menstrual blood loss). If ferritin is low, oral iron supplementation is reasonable; if ferritin is normal/high (typical of pure inflammatory anemia), iron therapy will not help and is not recommended.
- Recheck Hb/CBC after the acute infection resolves (2-4 weeks) - persistent anemia after recovery would prompt further workup (GI blood loss, gynecological causes given menorrhagia is common in this age group, or hematology referral).
3. Follow-up
- Repeat blood culture/Widal (paired sample) and CRP/ESR after completing antibiotics to confirm resolution.
- Stool culture follow-up is sometimes done to exclude chronic carrier state, especially if symptoms don't fully resolve.
- Vaccination (typhoid conjugate vaccine) can be discussed for future prevention, as supported by recent Cochrane and Lancet Global Health systematic reviews (PMID: 40326553, 38485426) showing good efficacy in endemic settings - relevant for the household/community, not for acute treatment of current illness.
This is standard textbook-based guidance for education purposes. Actual antibiotic selection, dosing, and duration must be prescribed by the treating physician, ideally guided by blood culture and sensitivity results and the patient's clinical status, allergies, renal/hepatic function, and any pregnancy status.
This is a shared conversation. Sign in to Orris to start your own chat.